Our data showed that DOCK1 deficiency resulted in sensitization of the patient-derived HCC organoids to metformin, while metformin combined with TBOPP showed strong, synergistic anti-tumor effects in metformin-resistant organoids (Figs. 2C–D and 4C). This evidence concerns the gene DOCK1 and neoplasm.